Latest Corporate News update ; Pharma... Feb 14
... Dec 03
INP104 is indicated in treatment of acute migraine... Nov 10
Results were presented at the 13th Clinical Trials in Alzheimer's Disease (CTAD) Meeting... Nov 09
Lonza and AstraZeneca collaborates to handle Covid challenge... Nov 04
first-ever approved site for commercial CAR-T cell therapy manufacturing in Asia... Oct 31
CStone is a biopharmaceutical company focused on the development and commercialization of innovative immuno-oncology and precision drugs ... Oct 30
Anti-tumor immune memory and iADC platform are showing results ... Oct 27
... Oct 27
Sai Life expands organizational transformation areas... Oct 27
Forian Inc. to Become Industry Leading Information, Analytics and Technology Provider for Healthcare and Cannabis Industries ... Oct 19
PALFORZIA recieves CHMP for Europe... Oct 19
Antiviral drugs are under lens for their effectiveness... Oct 06
Opdivo + Yervoy is the first new systemic therapy in over 15 years to be approved by the FDA ... Oct 03
HBI-8000 for Monotherapy Adult T-cell Leukemia-Lymphoma ATL ... Oct 01
Partners will develop Critical Immunomodulator for Cutaneous Leishmaniasis Therapeutic... Sep 30
The study will enrol up to 40 patients into two cohorts, randomized 1:1 to receive the active study drug plus standard treatment or placebo... Sep 29
China's Kangtai Biological Products cleared for human trial while Chinese Academy of Medical Sciences vaccine candidate is in mid-stage trial.... Sep 29
Zymo Research was granted the CE IVD mark for its DNA/RNA Shield reagent and collection devices. ... Sep 28
150 mg Single-Dose Vial, having received an approval from the United States Food and Drug Administration (U.S. FDA) earlier.... Sep 28
VMS, is commonly known as hot flashes and night sweats, in menopausal women.... Sep 26
The higher strength of Favipiravir 800 mg from Hetero has been approved by the Drug Controller General of India ... Sep 26
Russia pushes the cheapest covid drug Avifavir... Sep 25
Manufacturing agreement is for Vivet’s Investigational Gene Therapy for Wilson Disease... Sep 24
Oxford Nanopore Technologies Sign Non-Exclusive Licensing Agreement for Genetics Research’s Patented DNA Negative Enrichment Technology Platform ... Sep 23
-Advertisements-
Saturday, June 01, 2024
.jpg)
